Pfizer to purchase Seagen in $43 billion all-cash deal, cancer biotech’s stock pops 20%

Pfizer Inc. PFE, -0.18% plans to acquire cancer biotechnology company Seagen Inc. SGEN, -0.59% in a deal with a $43 billion enterprise value, the companies announced Monday morning. Pfizer intends to ...

Novavax Says ‘Substantial Doubt’ Around Its Continuing Operations

Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this year. In a quarterly earnings report issued after the market c...

Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped a financial windfall from its twin Covid-19 franchise—the top-selling vaccine and the leadi...

Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.

Pfizer executives say Wall Street analysts haven’t understood just how powerful a hit the company’s Covid-19 products will take this year. That’s the explanation the company’s chief financial officer,...

Pfizer (PFE) Q4 earnings 2022

Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garri...

With Pfizer Firmly in Value Territory, Here’s What Investors Are Missing

Investors have faced a conundrum in valuing companies that benefited from the Covid-19 pandemic. Pfizer’s (PFE) partnership with BioNTech (BNTX) in creating a vaccine, plus its antiviral, Paxlov...

What investors need to know about Pfizer’s latest downgrade

Pfizer’s PFE, -0.92% early-stage pipeline, though promising, is still too premature to make up for the looming loss of billions of dollars from the company’s COVID-19 franchise, which includes the vac...

Pfizer, Unum Group And Signature Bank

On 1/26/23, Pfizer, Unum Group, and Signature Bank will all trade ex-dividend for their respective upcoming dividends. Pfizer Inc will pay its quarterly dividend of $0.41 on 3/3/23, Unum Group will pa...

Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...

Powell’s in Sweden. Rates Will Likely Go Higher Still Despite Companies’ Pain.

Investors looking at Federal Reserve Chairman Jerome Powell’s speech at a conference at Sweden’s Riksbank Tuesday will be tempted to carefully parse his words for any hint as to when the interest-rate...

It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.

My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...

Why Pfizer Is Pulling Back on Research Into Rare Disease, Gene Therapy

Pfizer is planning to pull back on early-stage research into treatments for rare diseases, including the development of new viral-based gene therapies, the company told employees on Thursday afternoon...

Will Pfizer Share Price (NYSE: PFE) Sustain above $50? – Quarterly Growth Shines by 15%

Pfizer Share price has showcased some promising trading factors as it crossed 16% growth rate during this quarter. Pfizer Inc. (NYSE: PFE) is up 41% in the last five years, also slightly above the mar...

In Dividends We Trust – 3 Healthcare Bargains With Payout Increases

Oil titan John D. Rockefeller once quipped, “Do you know the only thing that gives me pleasure? It’s to see my dividends coming in.” While paying a dividend is not a hard criterion for every stock inc...

6 Defensive Healthcare Stocks for 2023

As investors face another uncertain year for public equities, large-cap healthcare stocks remain an attractive defensive play. They offer a shot at insulating capital from the downturn many still expe...

Stock Market Looks Poised to Rally as Bond Yield Falls

Text size Michael Nagle/Bloomberg The worst may be over for the stock market. Key equity indexes continued their autumn rally, and there could be more gains before the end of the year, helped by conti...

Elon Musk Complains of High Workload After Twitter Takeover

Elon Musk said he has “too much work” as the chief executive of both Twitter and Tesla as he undertakes mass layoffs and grapples with an advertising backlash at the social-media company.   “I am real...

Pfizer Stock’s Post-Covid Future Looks Healthy

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...

Pfizer’s Earnings Are Tuesday. What to Watch.

Pfizer is set to report its earnings on Tuesday, a week and a half after an executive told investors that the company was considering a list price for its Covid-19 vaccine of between $110 and $130 per...

Pfizer CEO Shares Companies Future Plans, Surely Affecting PFE Stock Price

Pfizer emerged as a prominent name as producer of Covid-19 vaccines and PFE stocks reflected good growth American multinational pharmaceutical company Pfizer (PFE) has new plans to diversify its produ...

Moderna Stock Takes Off on Cancer Vaccine News

Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will pay Moderna (MRNA) $250 million for...

Where Is the Stock Market Going? It Could Have a Messy Fall.

If 2022 were to end tomorrow, or the day after, it would enter the books as a dismal one for investors. The Dow Jones Industrial Average is down 13% year to date, the S&P 500 index is off 17%, and...

CVS Is in Advanced Talks to Buy Signify Health for Around $8 Billion

CVS Health is in advanced talks to acquire the home-healthcare company Signify Health for around $8 billion, according to people familiar with the matter. CVS appears to have beat out other heavy hitt...

Buy Haleon Stock. This GSK Spinoff Is a Bargain in Consumer Health.

In January, the United Kingdom pharmaceutical firm GSK turned down Unilever ’s offer of 50 billion pounds sterling, or about $60 billion, to buy its consumer healthcare division, saying the price was ...

3 Drug Companies Fall on Zantac Lawsuit Fears. It Shows the Power of Analysts.

Shares of Sanofi , GSK , and Haleon  fell for the second straight trading session Thursday on surging worries about litigation over Zantac, a heartburn drug that the Food and Drug Administration effec...

Pfizer, Moderna Take Different Paths as Vaccine Boom Ends

Pfizer is trying to add $25 billion to its 2030 revenue through acquisitions. Dan Kitwood – WPA Pool/Getty Images Text size Pfizer ’s $5.4 billion deal to acquire the biotech Global Blood Therap...

10 defensive stocks that can also provide you with growth and dividends over the long term

The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet. Mark Hulbert has called the recent...

Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion

Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...

A Recession Is Coming. These Are the Stocks to Hunker Down In.

Eli Salzmann loves nothing better than finding a company that’s a “dog of a stock with no momentum” but on the verge of better days. At its core, that is what value investing is all about. Over the co...

Moderna CEO: No ‘Crazy’ Deals. We’re Giving Cash to Shareholders.

Text size Moderna CEO Stephane Bancel says his company will keep returning cash to investors until it finds a better way of creating value. Jason Alden/Bloomberg Moderna ’s CEO is feeling no pressure ...

Moderna’s Earnings Are Wednesday. Here’s What to Expect.

Text size Moderna is developing two vaccines for the fall, one for the U.S. and the other for international markets. Sean Gallup/Getty Images As the U.S. prepares for a broad Covid-19 booster campaign...

Pfizer, Cisco, and 5 Other Stocks With the Cash Flow to Raise Their Dividends

A company’s free cash is a lifeline for dividends, buybacks and other uses of capital. If that well runs dry or even slows down, a company can be forced to dial down its spending. For this screen, Bar...